3-吗啉甲基苯硼酸 | 397843-58-2

• 物质功能分类: 化学试剂 - 有机试剂 - 硼酸
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-吗啉甲基苯硼酸
• 中文别名: [3-(吗啉-4-基甲基)苯]硼酸HCL；B-[3-(4-吗啉甲基)苯基]硼酸
• 英文名称: (3-(morpholinomethyl)phenyl)boronic acid
• 英文别名: 3-(Morpholinomethyl)phenylboronic acid；[3-(morpholin-4-ylmethyl)phenyl]boronic acid
• CAS: 397843-58-2
• 化学式: C₁₁H₁₆BNO₃
• mdl: MFCD10698498
• 分子量: 221.064
• InChiKey: VTSDPGUSDVMXDN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.8
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  52.9
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2934999090
• 危险性防范说明：
  P280,P305+P351+P338,P310
• 危险性描述：
  H302,H315,H319,H332,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-(Morpholinomethyl)phenylboronic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-(Morpholinomethyl)phenylboronic acid
CAS number: 397843-58-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H16BNO3
Molecular weight: 221.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-吗啉甲基苯硼酸 在 盐酸 、 palladium bis[bis(diphenylphosphino)ferrocene] dichloride 、 sodium carbonate 、 potassium carbonate 作用下， 以 1,4-二氧六环 、 乙醇 、 水 为溶剂， 反应 26.0h， 生成 N-(2-chloro-5-(3-(3-(morpholinomethyl)phenyl)-1H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)benzenesulfonamide
  参考文献：
  名称：

  Discovery of N-(2-chloro-5-(3-(pyridin-4-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide (FD274) as a highly potent PI3K/mTOR dual inhibitor for the treatment of acute myeloid leukemia

  摘要：

  DOI：

  10.1016/j.ejmech.2023.115543
• 作为产物：
  描述：

  potassium 3-(morpholinomethyl)-phenyltrifluoroborate 在 水 、 silica gel 作用下， 以 乙酸乙酯 为溶剂， 反应 3.0h， 以64%的产率得到3-吗啉甲基苯硼酸
  参考文献：
  名称：

  通过硅胶和水有效水解有机三氟硼酸盐

  摘要：

  开发了一种使用硅胶和 H 2 O水解有机三氟硼酸盐以揭示硼酸的通用、温和且有效的方法。事实证明，该方法可以耐受各种芳基-、杂芳基-、烯基-和烷基三氟硼酸盐以及结构多样的氨甲基化有机三氟硼酸盐。正如预期的那样，由于共振稳定的二氟硼烷中间体，富电子底物比缺电子底物更容易提供相应的硼酸。开发的方法进一步扩展用于将有机三氟硼酸盐转化为相应的硼酸酯。

  DOI：

  10.1021/jo901441u

文献信息

• Synthesis of Flavone Derivatives through Versatile Palladium-Catalyzed Cross-Coupling Reactions of Tosyloxy- and Mesyloxyflavones
  作者：Chau So、On Yuen、Wai Pang、Xiangmeng Chen、Zicong Chen、Fuk Kwong

  DOI：10.1055/s-0037-1611742

  日期：2019.4

  from abundant and biologically important hydroxyflavones were used to synthesize a series of functionalized flavones through versatile palladium-catalyzed cross-coupling reactions. A Pd(OAc)2/2-[2-(dicyclohexylphosphino)phenyl]-1-methyl-1H-indole system effectively catalyzed the reactions of a broad range of tosyloxy- and mesyloxyflavones as electrophilic coupling partners with various nucleophiles to

  来源于丰富且具有生物学重要性的羟基黄酮的甲苯磺酰氧基和甲磺酰氧基黄酮被用于通过多功能的钯催化交叉偶联反应合成一系列功能化黄酮。Pd(OAc)2/2-[2-(dicyclohexylphosphino)phenyl]-1-methyl-1H-indole 系统有效地催化了广泛的甲苯磺酰氧基和甲磺酰氧基黄酮作为亲电偶联伙伴与各种亲核试剂的反应，得到相应的产品良率高。成功使用了低至 0.1 mol% Pd 的催化剂负载量。重要的是，我们证明该协议在合成潜在的基于 chromen-4-one 的 DNA 依赖性蛋白激酶抑制剂的类似物方面提供了显着提高的效率。
• [EN] BICYCLIC HETEROARYL AMINE COMPOUNDS AS PI3K INHIBITORS<br/>[FR] COMPOSÉS AMINE HÉTÉROARYLES BICYCLIQUES UTILISÉS COMME INHIBITEURS DE LA PI3K
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2016064957A1

  公开（公告）日：2016-04-28

  Disclosed are compounds of Formula (I) or a salt thereof; wherein: X is N or CH; Q1 is: (i) C1, Br, I, -CN, -CH3, or -CF3; (ii) a 5-membered heteroaryl selected from pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, thiazolyl, triazolyl, oxadiazolyl, and thiadiazolyl; (iii) a 6?membered heteroaryl selected from pyridinyl, pyridazinyl, and pyrimidinyl; or (iv) a bicyclic heteroaryl selected from indolyl, pyrrolopyridinyl, pyrazolopyridinyl and benzo[d]oxazolyl; wherein each of said 5-membered, 6-membered, and bicyclic heteroaryl is substituted with zero to 1 Ra and zero to 1 Rb; and R1, R2, R3, R4, R5, R6, Ra, and Rb are defined herein. Also disclosed are methods of using such compounds as modulators of PI3K, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing inflammatory and autoimmune diseases.

  公开了Formula (I)或其盐的化合物；其中：X为N或CH；Q1为：(i) C1、Br、I、-CN、-CH3或-CF3；(ii)从吡咯基、吡唑基、咪唑基、噁唑基、噻唑基、三唑基、噁二唑基和噻二唑基中选择的5-成员杂芳基；(iii)从吡啶基、吡啶嗪基和嘧啶基中选择的6-成员杂芳基；或(iv)从吲哚基、吡咯吡啶基、吡唑吡啶基和苯并[d]噁唑基中选择的双环杂芳基；其中所述的5-成员、6-成员和双环杂芳基中的每一个都被零至1个Ra和零至1个Rb取代；R1、R2、R3、R4、R5、R6、Ra和Rb在此处被定义。还公开了使用这些化合物作为PI3K调节剂的方法，以及包含这些化合物的药物组合物。这些化合物在治疗、预防或减缓炎症性和自身免疫性疾病方面是有用的。
• Universal Solid-Phase Approach for the Immobilization, Derivatization, and Resin-to-Resin Transfer Reactions of Boronic Acids
  作者：Michel Gravel、Kim A. Thompson、Mark Zak、Christian Bérubé、Dennis G. Hall

  DOI：10.1021/jo0106501

  日期：2002.1.1

  amides, anilides, and ureas, respectively. Ugi multicomponent reactions on DEAM-PS-supported aminobenzeneboronic acids, derivatization of multifunctional arylboronic acids, and sequential reactions can also be carried out efficiently. These new DEAM-PS-supported arylboronic acids can be employed directly into resin-to-resin transfer reactions (RRTR). This type of multiresin process helps eliminate time-consuming

  含硼酸的分子广泛用于生物学，医学和合成领域。然而，这些化合物往往难以通过溶液相方法处理。在此，该问题通过用于官能化硼酸的衍生化的第一种通用固相方法的开发来解决。该方法基于使用二乙醇胺树脂锚，该锚通过避免在酯化过程中彻底去除水的需要而促进了硼酸的固定。通过在室温下在无水溶剂中简单搅拌，可以在数分钟内将多种硼酸固定在N，N-二乙醇氨基甲基聚苯乙烯（DEAM-PS，1）上。通过（1）DEAM-PS负载的对甲苯基硼酸的（1）NMR分析显示了形成具有假定的NB配位的双环二乙醇胺硼酸酯的证据。通过紫外光谱研究了DEAM-PS树脂对相同型号硼酸的水解裂解。水解和附着显示在快速达到的平衡下发生，并且需要大量过量的水（> 32当量）以实现从DEAM-PS实际定量释放硼酸。尽管它们对水和醇具有相对的敏感性，但可以用甲酰基，溴甲基，羧基或氨基官能化的DEAM-PS结合的芳基硼酸以良好或极高的收率转化成各种胺，酰
• Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of <i>Mycobacterium tuberculosis</i> Adenosine Kinase
  作者：Roberto A. Crespo、Qun Dang、Nian E. Zhou、Liam M. Guthrie、Thomas C. Snavely、Wen Dong、Kimberly A. Loesch、Takao Suzuki、Lanying You、Wei Wang、Theresa O’Malley、Tanya Parish、David B. Olsen、James C. Sacchettini

  DOI：10.1021/acs.jmedchem.9b00020

  日期：2019.5.9

  (MtbAdoK) is an essential enzyme of Mtb and forms part of the purine salvage pathway within mycobacteria. Evidence suggests that the purine salvage pathway might play a crucial role in Mtb survival and persistence during its latent phase of infection. In these studies, we adopted a structural approach to the discovery, structure-guided design, and synthesis of a series of adenosine analogues that displayed

  结核分枝杆菌腺苷激酶 (MtbAdoK) 是 Mtb 的一种必需酶，是分枝杆菌内嘌呤补救途径的一部分。有证据表明，嘌呤补救途径可能在 Mtb 感染潜伏期的存活和持续中发挥关键作用。在这些研究中，我们采用结构方法来发现、结构指导设计和合成一系列腺苷类似物，这些类似物对酶的抑制常数范围为 5 至 120 nM。其中两种化合物对 Mtb 表现出低微摩尔活性，半数最大有效抑制浓度为 1.7 和 4.0 μM。我们的选择性和初步药代动力学研究表明，与人类对应物相比，这些化合物对 MtbAdoK 具有更高程度的特异性，并且分别在啮齿动物中具有良好的耐受性。最后，晶体学研究显示了抑制、效力和选择性的分子基础，并揭示了 MtbAdoK 同二聚体特有的潜在治疗相关空腔的存在。
• [EN] AMINOPYRIDINE DERIVED COMPOUNDS AS LRRK2 INHIBITORS<br/>[FR] COMPOSÉS DÉRIVÉS DE L'AMINOPYRIDINE UTILISÉS EN TANT QU'INHIBITEURS DE LRRK2
  申请人：LUNDBECK & CO AS H

  公开号：WO2014106612A1

  公开（公告）日：2014-07-10

  The present invention is directed to aminopyridine derived compounds of formula (A). The compounds are considered useful for the treatment of diseases associated with LRRK2 such a Lewy body dementia, Parkinson's disease or cancer.

  本发明涉及公式（A）的氨基吡啶衍生物化合物。这些化合物被认为对与LRRK2相关的疾病如小体痴呆、帕金森病或癌症的治疗具有用处。